New ultrasound criteria could replace CT scans for liver cancer Follow-Up

NCT ID NCT07272083

Not yet recruiting Diagnosis Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new way to use contrast-enhanced ultrasound (CEUS) to see if liver cancer treatment (ablation) worked. Researchers will compare the new CEUS criteria with standard CT or MRI scans in 200 adults. If accurate, this could make follow-up safer and easier by avoiding radiation and contrast dyes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Contrast-enhanced ultrasound (CEUS) with LI-RADS TRA criteria
What this could lead to: If successful, this could make follow-up scans simpler and safer for liver cancer patients by using ultrasound instead of CT or MRI.
What could go wrong: This is an early observational study with 200 people, so results may not apply to all patients. The new criteria might not be accurate enough to replace current imaging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA

Contacts and locations

Locations

Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italia

Roma, 00168, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.